CVRx names John Landry CFO, effective Nov. 6

CVRX•2026-11-05

CVRx appointed John Landry chief financial officer, effective Nov. 6, 2026, succeeding Jared Oasheim, whose resignation was previously announced.

1. CFO appointment

CVRx appointed John Landry chief financial officer, effective Nov. 6, 2026, succeeding Jared Oasheim. Landry brings more than 20 years of financial leadership experience in the medical device industry.

CVRx names John Landry CFO, effective Nov. 6

1. CFO appointment

Related News

Caribou Biosciences Q3 net loss narrows to $26.61 million; revenue falls 27% to $1.61 million

FIGS Q3 revenue rises 26% on increase in orders, higher AOV

NuScale Power Q3 revenue misses estimates as RoPower engineering work ends

Inogen Q3 revenue falls on lower international sales

Xponential Fitness Q3 revenue falls on lower franchise fees, fewer equipment installations